CGEN
Compugen Ltd
Price:  
1.61 
USD
Volume:  
564,354.00
Israel | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CGEN EV/EBITDA

4.3%
Upside

As of 2024-12-13, the EV/EBITDA ratio of Compugen Ltd (CGEN) is 12.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CGEN's latest enterprise value is 136.94 mil USD. CGEN's TTM EBITDA according to its financial statements is 11.05 mil USD. Dividing these 2 quantities gives us the above CGEN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 12.1x - 13.2x 12.3x
Forward P/E multiples 12.6x - 14.4x 13.6x
Fair Price 1.58 - 1.86 1.68
Upside -2.1% - 15.7% 4.3%
1.61 USD
Stock Price
1.68 USD
Fair Price

CGEN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-11-29 12.23
2024-11-27 12.39
2024-11-26 11.66
2024-11-25 10.77
2024-11-22 10.77
2024-11-21 11.10
2024-11-20 10.93
2024-11-19 11.02
2024-11-18 10.93
2024-11-15 10.77
2024-11-14 11.42
2024-11-13 12.23
2024-11-12 12.31
2024-11-11 13.45
2024-11-08 13.77
2024-11-07 14.01
2024-11-06 13.28
2024-11-05 12.64
2024-11-04 12.64
2024-11-01 13.20
2024-10-31 12.31
2024-10-30 12.64
2024-10-29 12.88
2024-10-28 13.04
2024-10-25 13.12
2024-10-24 13.28
2024-10-23 13.04
2024-10-22 12.96
2024-10-21 13.20
2024-10-18 13.20
2024-10-17 13.37
2024-10-16 13.12
2024-10-15 12.56
2024-10-14 12.96
2024-10-11 13.28
2024-10-10 13.28
2024-10-09 13.45
2024-10-08 13.37
2024-10-07 13.69
2024-10-04 14.18
2024-10-03 13.77
2024-10-02 14.99
2024-10-01 14.34
2024-09-30 14.01
2024-09-27 13.97
2024-09-26 13.53
2024-09-25 13.45
2024-09-24 13.61
2024-09-23 13.61
2024-09-20 14.18